Sandbox: malabsorption: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
! | ! | ||
! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" |Cause | ! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" |Cause | ||
| colspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" |Clinical manifestation | | colspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" |'''Clinical manifestation''' | ||
! colspan="4" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Lab findings | ! colspan="4" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Lab findings | ||
! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" |Additional findings | ! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" |Additional findings | ||
Line 13: | Line 13: | ||
|- | |- | ||
! | ! | ||
! colspan="6" align="center" style="background:#4479BA; color: #FFFFFF;" | ! colspan="6" align="center" style="background:#4479BA; color: #FFFFFF;" |Symptoms | ||
!align="center" style="background:#4479BA; color: #FFFFFF;" |Signs | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Signs | ||
|- | |- | ||
! | ! | ||
Line 27: | Line 27: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Bloody | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Bloody | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Fatty | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Fatty | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" |WBC | ! align="center" style="background:#4479BA; color: #FFFFFF;" |WBC | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Hgb | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Hgb | ||
Line 36: | Line 35: | ||
! align="center" style="background:#DCDCDC;" |[[Whipple's disease]] | ! align="center" style="background:#DCDCDC;" |[[Whipple's disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | ||
Line 69: | Line 68: | ||
! align="center" style="background:#DCDCDC;" |[[Celiac disease]] | ! align="center" style="background:#DCDCDC;" |[[Celiac disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 103: | Line 102: | ||
! align="center" style="background:#DCDCDC;" |[[Tropical sprue]] | ! align="center" style="background:#DCDCDC;" |[[Tropical sprue]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 130: | Line 129: | ||
! align="center" style="background:#DCDCDC;" |[[Crohns disease]] | ! align="center" style="background:#DCDCDC;" |[[Crohns disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 157: | Line 156: | ||
! align="center" style="background:#DCDCDC;" |[[Ulcerative colitis]] | ! align="center" style="background:#DCDCDC;" |[[Ulcerative colitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 192: | Line 191: | ||
! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]] | ! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | ||
Line 219: | Line 218: | ||
! align="center" style="background:#DCDCDC;" |[[VIPoma]] | ! align="center" style="background:#DCDCDC;" |[[VIPoma]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 253: | Line 252: | ||
! align="center" style="background:#DCDCDC;" |[[Zollinger-Ellison syndrome]] | ! align="center" style="background:#DCDCDC;" |[[Zollinger-Ellison syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 276: | Line 275: | ||
! align="center" style="background:#DCDCDC;" |[[Eosinophilic gastroenteritis]] | ! align="center" style="background:#DCDCDC;" |[[Eosinophilic gastroenteritis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 302: | Line 301: | ||
! align="center" style="background:#DCDCDC;" |[[Primary bile acid malabsorption]] | ! align="center" style="background:#DCDCDC;" |[[Primary bile acid malabsorption]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 325: | Line 324: | ||
! align="center" style="background:#DCDCDC;" |[[Abetalipoproteinemia]] | ! align="center" style="background:#DCDCDC;" |[[Abetalipoproteinemia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 353: | Line 352: | ||
! align="center" style="background:#DCDCDC;" |[[Microscopic colitis]] | ! align="center" style="background:#DCDCDC;" |[[Microscopic colitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 385: | Line 384: | ||
! align="center" style="background:#DCDCDC;" |[[Hyperthyroidism]] | ! align="center" style="background:#DCDCDC;" |[[Hyperthyroidism]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | ||
Line 416: | Line 415: | ||
! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]] | ! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 444: | Line 443: | ||
! align="center" style="background:#DCDCDC;" |[[Irritable bowel syndrome]] | ! align="center" style="background:#DCDCDC;" |[[Irritable bowel syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 465: | Line 464: | ||
! align="center" style="background:#DCDCDC;" |[[Chronic pancreatitis]] | ! align="center" style="background:#DCDCDC;" |[[Chronic pancreatitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 483: | Line 482: | ||
! align="center" style="background:#DCDCDC;" |[[Cirrhosis]] | ! align="center" style="background:#DCDCDC;" |[[Cirrhosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 500: | Line 499: | ||
! align="center" style="background:#DCDCDC;" |[[Short bowel syndrome]] | ! align="center" style="background:#DCDCDC;" |[[Short bowel syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 517: | Line 516: | ||
! align="center" style="background:#DCDCDC;" |Intestinal [[lymphoma]] | ! align="center" style="background:#DCDCDC;" |Intestinal [[lymphoma]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 534: | Line 533: | ||
! align="center" style="background:#DCDCDC;" |[[Agammaglobulinemia]] | ! align="center" style="background:#DCDCDC;" |[[Agammaglobulinemia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 551: | Line 550: | ||
! align="center" style="background:#DCDCDC;" |Intestinal [[lymphangiectasia]] | ! align="center" style="background:#DCDCDC;" |Intestinal [[lymphangiectasia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 568: | Line 567: | ||
! align="center" style="background:#DCDCDC;" |[[Amyloidosis]] | ! align="center" style="background:#DCDCDC;" |[[Amyloidosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 585: | Line 584: | ||
! align="center" style="background:#DCDCDC;" |[[Mastocytosis]] | ! align="center" style="background:#DCDCDC;" |[[Mastocytosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 602: | Line 601: | ||
! align="center" style="background:#DCDCDC;" |[[Small intestinal bacterial overgrowth]] | ! align="center" style="background:#DCDCDC;" |[[Small intestinal bacterial overgrowth]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 619: | Line 618: | ||
! align="center" style="background:#DCDCDC;" |Drug induced [[enteritis]] | ! align="center" style="background:#DCDCDC;" |Drug induced [[enteritis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 636: | Line 635: | ||
! align="center" style="background:#DCDCDC;" |[[HIV AIDS|HIV infection]] | ! align="center" style="background:#DCDCDC;" |[[HIV AIDS|HIV infection]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 652: | Line 651: | ||
! align="center" style="background:#DCDCDC;" |[[Giardiasis]] | ! align="center" style="background:#DCDCDC;" |[[Giardiasis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 668: | Line 667: | ||
! align="center" style="background:#DCDCDC;" |[[Strongyloidiasis]] | ! align="center" style="background:#DCDCDC;" |[[Strongyloidiasis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 684: | Line 683: | ||
! align="center" style="background:#DCDCDC;" |[[Tuberculosis]] | ! align="center" style="background:#DCDCDC;" |[[Tuberculosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | |
Revision as of 16:19, 29 November 2017
Abbreviations: WBC: White blood cells; Plt: Platelets, Hgb: Hemoglobin, IgE: Immunoglobulin E, IgA: Immunoglobulin A
Cause | Clinical manifestation | Lab findings | Additional findings | Cause/Pathogenesis | Gold standard diagnosis | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Signs | ||||||||||||||
Diarrhea | Fever | Abdominal pain | Weight loss | ||||||||||||
Watery | Bloody | Fatty | WBC | Hgb | Plt | Other lab findings | |||||||||
Whipple's disease | + | - | + | ± | + | + |
|
↓ | ↓ | ↓/↑ |
| ||||
Celiac disease | ± | - | ± | - | + | + | - | ↓ | - |
|
|
|
|||
Tropical sprue | + | - | + | + | + | + |
|
- | ↓ | - |
|
| |||
Crohns disease | + | + | + | + | + | + | ↑ | ↓ | ↑ |
|
|
|
| ||
Ulcerative colitis | + | + | + | + | + | + |
|
↑ | ↓ | ↑ |
|
|
|
| |
Cystic fibrosis | - | - | + | ± | + | + |
|
- | ↓ | - |
|
|
| ||
VIPoma | + | - | + | - | + | + | - | - | - |
|
|
| |||
Zollinger-Ellison syndrome | + | - | + | - | + | + | - | ↓ | - |
|
| ||||
Eosinophilic gastroenteritis | + | - | + | - | + | + | ↑ | - | - |
|
|
|
| ||
Primary bile acid malabsorption | + | - | + | - | + | + | - | ↓ | - |
|
|
| |||
Abetalipoproteinemia | + | - | + | - | + | + | - | - | - |
|
|
|
| ||
Microscopic colitis | + | + | - | - | + | + | - | ↓ | - |
|
|
|
| ||
Hyperthyroidism | + | - | - | ± | + | + | - | - | - |
|
|||||
Lactose intolerance | + | - | - | - | + | - | - | - | - |
|
|
| |||
Irritable bowel syndrome | ± | - | ± | - | ± | - |
|
- | - | - |
| ||||
Chronic pancreatitis | + | - | + | - | + | + |
| ||||||||
Cirrhosis | + | - | + | + | + | + | |||||||||
Short bowel syndrome | - | ||||||||||||||
Intestinal lymphoma | |||||||||||||||
Agammaglobulinemia | |||||||||||||||
Intestinal lymphangiectasia | |||||||||||||||
Amyloidosis | |||||||||||||||
Mastocytosis | |||||||||||||||
Small intestinal bacterial overgrowth | |||||||||||||||
Drug induced enteritis | |||||||||||||||
Infection | HIV infection | ||||||||||||||
Giardiasis | |||||||||||||||
Strongyloidiasis | |||||||||||||||
Tuberculosis |